Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England

• Príomhchruthaitheoirí: Kilcoyne A (Údar), Jordan E (Údar), Thomas K (Údar), Pepper AN (Údar), Zhou A (Údar), Chappell D (Údar), Amarapala M (Údar), Thériault RK (Údar), Thompson M (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Dove Medical Press, 2022-04-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Adrian Kilcoyne,1 Edward Jordan,1 Kimberly Thomas,2 Alicia N Pepper,2 Allen Zhou,2 Dale Chappell,1 Miyuru Amarapala,1 Rachel-Karson Thériault,2 Melissa Thompson2 1HEOR, Humanigen Inc, Burlingame, CA, USA; 2Value & Evidence Services, EVERSANA, Burlington, Ontario, CanadaCorrespondence: Adrian Kil...